TY  - CONF
AU  - Lopez-Pedrera, C.
AU  - Munoz-Barrera, L.
AU  - Escudero Contreras, A.
AU  - Aguirre-Zamorano, M. A.
AU  - Ortiz Buitrago, P.
AU  - Lopez-Medina, C.
AU  - Calvo Gutierrez, J.
AU  - Ortega Castro, R.
AU  - Pilar, F. U.
AU  - Sanchez-Pareja, I.
AU  - Abalos-Aguilera, M. C.
AU  - Barbarroja Puerto, N.
AU  - Collantes Estevez, E.
AU  - Perez-Sanchez, C.
PY  - 2022
DO  - 10.1136/annrheumdis-2022-eular.4733
SN  - 0003-4967
UR  - http://hdl.handle.net/10668/20121
T2  - Annals of the rheumatic diseases
AB  - Background: Systemic autoimmune diseases such as Rheumatoid Arthritis(RA) and Systemic Lupus Erythematosus (SLE) are characterised by aberrantautoimmune and inflammatory processes, which are directly associated with the development and progression of...
LA  - en
PB  - BMJ Group
KW  - Arthritis, rheumatoid
KW  - Lupus erythematosus, systemic
KW  - Reverse transcriptase polymerase chain reaction
KW  - Correlation of data
KW  - Disruptive technology
KW  - Gene ontology
KW  - Proteomics
KW  - Antibodies
KW  - Biomarkers
TI  - IDENTIFICATION OF NOVEL BIOMARKERS OF DISEASE ACTIVITY IN SYSTEMIC AUTOIMMUNE DISEASES THROUGH NEXT GENERATION PROTEOMICS
TY  - conference output
VL  - 81
ER  -